French Competition Authority Fines Sanofi-Aventis EUR 40.6 Million for Disparaging Competing Generic ProductsFirm Thought Leadership
FTC Proposed Rulemaking Attacks Pharma Licensing Transactions, Likely Increases HSR Filing BurdenFirm Thought Leadership
Consumer Class Actions Face Hurdles in CaliforniaFirm Thought Leadership
Supreme Court Denies Review of Controversial Daubert RulingFirm Thought Leadership
Baker Botts Antitrust Partner Michael Perry, along with Victor Rufino, Attorney General of CADE, Brazil’s competition authority, and Esther Flesch, Partner at Trench, Rossi and Watanabe, are speakers at the upcoming International Congress of Management in Health in Sao Paulo, Brazil.